Artikel

Sociale determinanten van SARS-CoV-2 vaccinatiebereidheid en opkomst in Amsterdam en Madrid

Verminderen van inadequaat antibioticagebruik in verpleeghuizen

People with a migration background and those with lower socioeconomic status (SES) have been disproportionately affected by SARS-CoV-2, in terms of higher rates of infections and COVID-19-related hospitalizations and mortality. In Amsterdam, where nearly 60% of the population has a migration background, research within the HELIUS cohort revealed higher infection rates among individuals of South-Asian Surinamese, African Surinamese, Turkish, Moroccan and especially Ghanaian origin compared to those of Dutch origin. Lower vaccination intents were observed among these groups prior to the COVID-19 vaccine rollout, with factors such as feeling that COVID-19 was exaggerated in the media, female sex, and age under 45 years being common determinants associated with lower SARS-CoV-2 vaccination intent. The actual uptake was also lower in most ethnic minority groups compared to the Dutch group, except in the South-Asian Surinamese group. In this study, we aim to compare the association between SARS-CoV-2 vaccination intent and actual uptake between ethnic groups, and to explore whether determinants of intent and uptake are similar. Additionally, we aim to gain more insight into the role of socioeconomic factors in the SARS-CoV-2 vaccination uptake. In collaboration with the National Center of Epidemiology in Madrid, we will investigate social determinants of SARS-CoV-2 vaccination uptake in Madrid and we will compare these findings with data from Amsterdam. Comparing SES disparities in vaccination uptake between two contexts with an ethnically diverse population and large within city socioeconomic variation will yield insights into important determinants of vaccination uptake, but also into which strategies implemented to encourage uptake seemed to work. These insights can in turn be used to inform efforts to increase vaccination uptake among different populations, ultimately reducing health inequalities.

Looptijd: 1-1-2024 tot 31-8-2024